Mydecine Innovations Group signs definitive agreement to acquire Mindleap Health's advanced digital telehealth platform

Mydecine Innovations Group signs definitive agreement to acquire Mindleap Health's advanced digital telehealth platform

Press releases may be edited for formatting or style | June 17, 2020 Health IT Telemedicine

About Mydecine Innovations Group

Mydecine Innovation's Group is a life sciences company focused on the development and commercialization of products and services that contribute to improving overall health and wellbeing. The company's mission is to create a healthier world through advanced technologies, natural products, and psychedelic derived medicines. Mydecine Innovations Group owns a group of trailblazing companies that are focused on helping millions of people live better lives and our portfolio includes:

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.


Cannabis & Fungi Based Products
Mycology Research & Development
Disruptive Technology
Therapeutic Treatment Facilities
Large-Scale Distribution
Psychedelic-Derived Medicines


About Mindleap Health
Mindleap Health is developing an advanced digital telehealth platform that will provide support for people that are looking to achieve personal transformations and overcome mental health challenges. MindLeap is the only digital telehealth platform that combines telemedicine with mood, emotion, and habit tracking. This is a paradigm shift to conventional mental health as Mindleap personalized support and users have the tools needed to track their progress and take control of their mental health.


SOURCE Mydecine Innovations Group Inc.

Back to HCB News

You Must Be Logged In To Post A Comment